wb 4101 has been researched along with talipexole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mottram, DR | 1 |
| Cheng, L; Corboz, MR; Egan, RW; Hey, JA; Jakway, J; McCormick, K; Rizzo, CA; Ruck, LM; Shah, H; Umland, SP; Wan, Y | 1 |
2 other study(ies) available for wb 4101 and talipexole
| Article | Year |
|---|---|
Pre-junctional alpha 2-adrenoceptor activity of B-HT920.
Topics: Adrenergic alpha-Agonists; Animals; Azepines; Clonidine; Dioxanes; Drug Interactions; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Rats; Rats, Inbred Strains; Yohimbine | 1983 |
Postjunctional alpha(2C)-adrenoceptor contractility in human saphenous vein.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Animals; Azepines; Brimonidine Tartrate; CHO Cells; Cricetinae; Dioxanes; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Quinoxalines; Receptors, Adrenergic, alpha-2; Saphenous Vein; Vasoconstriction; Yohimbine | 2001 |